Developed in close collaboration with leading biopharma partners, Genedata Expressionist evolves with each release to meet the latest industry requirements, enabling out-of-the-box implementation of custom solutions. Genedata Expressionist 17.5 goes further by introducing an extended API that takes customization to a new level. Biopharma organizations can now seamlessly integrate bespoke software functionalities into Genedata Expressionist, enabling internal experts—or Genedata professional services—to leverage their domain knowledge and programming skills to deliver data processing, analysis, and reporting workflows that meet unique business needs.
“To maximize efficiencies in today’s data-driven drug development processes, automation must extend across entire analytical workflows, including traditional process bottlenecks such as expert review” stated Othmar Pfannes, Ph.D., CEO of Genedata. “By simplifying and accelerating data review and offering unmatched data processing flexibility, this release solidifies the position of Genedata Expressionist as the industry front-runner for streamlining and automating MS-based analytical workflows and provides biopharma organizations with faster, more accurate, and more efficient ways of working.”
About Genedata
Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.
http://www.genedata.com
LinkedIn https://www.linkedin.com/company/genedata/
Twitter https://twitter.com/Genedata
YouTube https://www.youtube.com/GenedataSoftware
Contact
Allison Kurz
Genedata
Public Relations
[email protected]
Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company’s products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.
Media Contact
Allison Kurz, Genedata, +41 61 511 84 00, [email protected], www.genedata.com
SOURCE Genedata
